Iris Acquisition Corp II
Iris Acquisition Corp II Fundamental Analysis
Iris Acquisition Corp II (IRAB) shows weak financial fundamentals with a PE ratio of 228.92, profit margin of 0.00%, and ROE of -13.91%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 20.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze IRAB's fundamental strength across five key dimensions:
Efficiency Score
WeakIRAB struggles to generate sufficient returns from assets.
Valuation Score
WeakIRAB trades at a premium to fair value.
Growth Score
WeakIRAB faces weak or negative growth trends.
Financial Health Score
ExcellentIRAB maintains a strong and stable balance sheet.
Profitability Score
WeakIRAB struggles to sustain strong margins.
Key Financial Metrics
Is IRAB Expensive or Cheap?
P/E Ratio
IRAB trades at 228.92 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, IRAB's PEG of 2.29 indicates potential overvaluation.
Price to Book
The market values Iris Acquisition Corp II at -16.03 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -3416.44 times EBITDA. This is generally considered low.
How Well Does IRAB Make Money?
Net Profit Margin
For every $100 in sales, Iris Acquisition Corp II keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-13.91 in profit for every $100 of shareholder equity.
ROA
Iris Acquisition Corp II generates $0.26 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.00 in free cash annually.
FCF Yield
IRAB converts -0.01% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
228.92
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
2.29
vs 25 benchmark
P/B Ratio
Price to book value ratio
-16.03
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-0.01
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.94
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.14
vs 25 benchmark
ROA
Return on assets percentage
0.003
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How IRAB Stacks Against Its Sector Peers
| Metric | IRAB Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 228.92 | 18.83 | Worse (Expensive) |
| ROE | -13.91% | 822.00% | Weak |
| Net Margin | 0.00% | 2005.00% | Weak |
| Debt/Equity | -0.01 | 1.01 | Strong (Low Leverage) |
| Current Ratio | 2.94 | 673.11 | Strong Liquidity |
| ROA | 0.26% | -23560.00% (disorted) | Weak |
IRAB outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Iris Acquisition Corp II's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical